Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$927,770,000
+$197,520,000 QoQ
Shares Held
1,000,000
0.0% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
8.33%
of 13F equity value
Holder Rank
#6
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. ARGX ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,111,111 | $1,363,235,525 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $1,073,713,002 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,833,333 | $984,408,154 | |
| 4 | ARGX |
Argenx SE
This page
|
1,000,000 | $927,770,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,355,555 | $925,591,288 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $857,129,238 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,297,000 | $430,182,160 | |
| 8 | CYTK |
Cytokinetics Inc
|
4,999,999 | $425,949,914 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $927,770,000 | 1,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $730,250,000 | 1,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $832,540,500 | 990,000 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $730,184,400 | 990,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $647,683,500 | 1,175,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $731,058,035 | 1,235,177 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $761,657,205 | 1,238,467 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $671,348,191 | 1,238,467 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $532,590,348 | 1,238,467 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $487,609,227 | 1,238,467 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $469,666,323 | 1,234,567 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $491,630,000 | 1,000,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $492,423,855 | 1,263,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $479,696,750 | 1,287,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $479,430,200 | 1,265,555 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $446,804,192 | 1,265,555 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $479,493,478 | 1,265,555 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $395,714,050 | 1,255,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $337,933,350 | 965,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $285,843,000 | 946,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $284,962,755 | 946,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $254,873,445 | 925,500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $265,416,225 | 902,500 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $236,924,300 | 902,500 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $218,473,100 | 970,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $123,365,145 | 936,500 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||